Y
Yoichi Aoki
Researcher at University of the Ryukyus
Publications - 214
Citations - 3094
Yoichi Aoki is an academic researcher from University of the Ryukyus. The author has contributed to research in topics: Cervical cancer & Medicine. The author has an hindex of 29, co-authored 187 publications receiving 2644 citations. Previous affiliations of Yoichi Aoki include Niigata University.
Papers
More filters
Journal Article
Use of Adoptive Transfer of Tumor-infiltrating Lymphocytes Alone or in Combination with Cisplatin-containing Chemotherapy in Patients with Epithelial Ovarian Cancer
Yoichi Aoki,Koichi Takakuwa,Shoji Kodama,Kenichi Tanaka,Masaaki Takahashi,Akiteru Tokunaga,Takeshi Takahashi +6 more
TL;DR: It appears that the adoptive transfer of tumor-infiltrating lymphocytes achieves high response rates even without recombinant interleukin-2 administration and that the prospect of combined therapy using TILs and cisplatin offers hope for increasing the cure rate and long-term survival.
Journal ArticleDOI
Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.
Yasuhiko Ebina,Nobuo Yaegashi,Hidetaka Katabuchi,Satoru Nagase,Yasuhiro Udagawa,Toru Hachisuga,Tsuyoshi Saito,Mikio Mikami,Yoichi Aoki,Hiroyuki Yoshikawa +9 more
TL;DR: The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.
Journal ArticleDOI
High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Yoichi Aoki,Masaru Sasaki,Minoru Watanabe,Takaaki Sato,Ikunosuke Tsuneki,Hiroshi Aida,Kenichi Tanaka +6 more
TL;DR: For patients with node-positive stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy with pelvic lymph node dissection and postoperative irradiation, it may be worthwhile to consider new strategies to improve survival.
Journal ArticleDOI
Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule ☆
Takafumi Toita,Ryo Kitagawa,Tetsutaro Hamano,Kenji Umayahara,Yasuyuki Hirashima,Yoichi Aoki,Masahiko Oguchi,Mikio Mikami,Ken Takizawa +8 more
TL;DR: It is demonstrated that CCRT using HDR-ICBT with a low cumulative RT dose schedule achieved comparable outcome as those achieved with global dose schedules (EQD2=85 Gy) with a lower incidence of late toxicity for locally advanced uterine cervical cancer in a Japanese population.
Journal ArticleDOI
Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor.
Akira Kikuchi,Yoichi Aoki,Susumu Sugaya,Takehiro Serikawa,Koichi Takakuwa,Kenichi Tanaka,Norio Suzuki,Hiroshi Kikuchi +7 more
TL;DR: In the mEIIL peritoneal disseminated tumor-nude mouse model, herpes simplex thymidine kinase gene transfer with the novel liposomes followed by ganciclovir (GCV) treatment, resulted in significantly longer survival compared with control mice.